Medicare Enrolled

Dr. Harish Gagneja, MD

Gastroenterology · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1015 E 32ND ST STE 300, Austin, TX 78705
5124699966
In practice since 2005 (20 years)
NPI: 1235114786 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gagneja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gagneja? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gagneja

Dr. Harish Gagneja is a gastroenterology in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Gagneja performed 1,245 Medicare services across 1,176 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gagneja received a total of $643,542 from 72 pharmaceutical and/or device companies across 1336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gagneja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 16% volume in TX$ $643,542 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,245
Medicare services
Top 16% in TX for gastroenterology
1,176
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)226$61$160
Removal of polyps or growths of large bowel using an endoscope with mechanical snare190$174$1,171
Office visit, established patient (30-39 min)189$88$235
Upper GI endoscopy with biopsy175$68$592
Colonoscopy with biopsy131$72$883
New patient office visit (30-44 min)77$73$235
New patient office visit (45-59 min)47$103$365
Measurement of liver stiffness34$23$75
Colorectal cancer screening; colonoscopy on individual at high risk33$177$803
Insertion of guide wire with dilation of esophagus using a flexible endoscope28$97$694
Removal of large bowel tissue using a flexible endoscope25$248$818
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope24$66$575
Imaging of digestive tract done from the inside of the digestive tract22$611$2,200
Destruction of polyp or growth of esophagus using a flexible endoscope18$119$486
Injection beneath lining of large bowel using a flexible endoscope15$12$855
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk11$179$818
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$643,542
Total received (2018-2024)
Avg $91,935/year across 7 years
Top 1% in TX for gastroenterology
72
Companies
1,336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$390,880 (60.7%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$148,882 (23.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$46,974 (7.3%)
Other
Charitable contributions, space rental, and other categories
$30,935 (4.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,871 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$123,520
2023
$47,185
2022
$76,251
2021
$47,488
2020
$161,905
2019
$76,977
2018
$110,216

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Covidien LP
$155,316
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107,551
Phathom Pharmaceuticals, Inc.
$100,127
Medtronic, Inc.
$58,420
Synergy Pharmaceuticals Inc
$56,391
GENZYME CORPORATION
$46,101
Regeneron Healthcare Solutions, Inc.
$23,753
Gilead Sciences, Inc.
$21,476
RedHill Biopharma Inc.
$15,412
Ferring Pharmaceuticals Inc.
$7,964
ABBVIE INC.
$7,875
Celgene Corporation
$4,193
E.R. Squibb & Sons, L.L.C.
$4,182
Takeda Pharmaceuticals U.S.A., Inc.
$4,001
Aries Pharmaceuticals, Inc.
$3,391
GastroGPO, LLC
$3,232
Wilson Cook Medical Incorporated
$3,184
Ferring International Pharmascience Center US
$3,000
Micro-tech Endoscopy USA, Inc.
$2,506
Janssen Scientific Affairs, LLC
$1,753
Alfasigma USA, Inc.
$1,529
PFIZER INC.
$1,442
Cook Medical LLC
$1,035
AbbVie, Inc.
$1,034
AbbVie Inc.
$1,033
Ambu Inc.
$911
Janssen Biotech, Inc.
$778
Shire North American Group Inc
$648
Allergan Inc.
$574
Boston Scientific Corporation
$444
BOSTON SCIENTIFIC CORPORATION
$409
Creo Medical Inc.
$298
Olympus America Inc.
$284
UCB, Inc.
$271
Ardelyx, Inc.
$211
Exact Sciences Corporation
$174
C2 Therapeutics, Inc
$157
PENTAX of America, Inc.
$147
Ethicon US, LLC
$143
ERBE USA INC
$135
AnX Robotica Corp
$126
GI Supply, Inc.
$123
Nestle HealthCare Nutrition Inc.
$120
Lilly USA, LLC
$116
Medivators Inc.
$108
Cook Incorporated
$108
NESTLE HEALTHCARE NUTRITION INC.
$105
Amgen Inc.
$102
Ironwood Pharmaceuticals, Inc
$101
CONMED Corporation
$100
Endogastric Solutions, Inc
$94
AIMMUNE THERAPEUTICS, INC.
$89
Johnson & Johnson Health Care Systems Inc.
$87
Iterative Scopes, Inc.
$70
Merck Sharp & Dohme LLC
$62
Madrigal Pharmaceuticals
$61
Axonics Modulation Technologies, Inc.
$56
QOL Medical, LLC
$50
INTERCEPT PHARMACEUTICALS, INC.
$43
Intercept Pharmaceuticals, Inc.
$42
Prometheus Laboratories Inc.
$36
Organon LLC
$33
Celltrion USA Inc.
$32
ERBE USA Inc
$31
Mauna Kea Technologies, Inc.
$29
Shionogi Inc
$23
AMAG Pharmaceuticals, Inc.
$22
IRONWOOD PHARMACEUTICALS, INC
$21
EISAI INC.
$20
Cumberland Pharmaceuticals, Inc.
$17
Organon Llc
$17
CapsoVision, Inc.
$13
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
AGILE · AMITIZA · APRISO · AVSOLA · Aemcolo · AirWave · All Products · Amitiza · Axonics r-SNM System · BARRX · BILIARY STENT INTRODUCER · Barrx · C2 CRYOBALLOON · CLENPIQ · CONMED Biliary · CONMED HEMOSTASIS · COOK MEDICAL HEMOSPRAY · COOK MEDICAL HEMOSTASIS · CREON · CapsoCam Plus · Cimzia · Cologuard Collection Kit · Computer Software · Cook Medical Biliary · Cook Medical Evolution · Cook Medical Hemospray · Cook Medical Metal Stents · Cytosponge · DEFENDO STERILE SINGLE USE VALVES · DIFICID · DUPIXENT · Dexilant · ELEVIEW · ENDOFLIP · ENTYVIO · ESOPHYX · EXALT BX 2 · EXALT BX 4 · EXALT Model D · Enbrel · EndoClot PHS · EndoFlip · Endocuff Vision · Entyvio · Epclusa · FERAHEME · FUSION · GATTEX · GENERAL THERAPIES · GENERAL BILIARY DEVICES · GENERAL ENDOCHOICE · GENERAL BILIARY DEVICES · GI GENIUS · GI Genius · HADLIMA · HIGH DEFINITION LCD MONITOR · HUMIRA · Humira · IBSRELA · INFLECTRA · INSPIRA · INSTINCT · Instinct · KRISTALOSE · LINX Reflux Management System · LINZESS · Lenvima · Linzess · Lockado · MAVYRET · MOTEGRITY · Mavyret · Movantik · N/A · OCALIVA · OMVOH · ORISE · OverStitch NXT Endoscopic Suturing System · Ozanimod · PILLCAM · PLENVU · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKOUT · SKYRIZI · SONARMED AIRWAVE · SPEEDBOAT · STELARA · SUCRAID · Smart Pill · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VIO3 APC3 · VIO300D · VOQUEZNA · VOWST · WATCHMAN · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (61%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in TX.

Equivalent to $51,690 per 100 Medicare services performed
Looking for a gastroenterology in Austin?
Compare gastroenterologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
78
Per 100K population
6.0
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gagneja is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gagneja experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gagneja performed 226 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gagneja receive payments from pharmaceutical companies?
Yes. Dr. Gagneja received a total of $643,542 from 72 companies across 1,336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gagneja's costs compare to other gastroenterologys in Austin?
Dr. Gagneja's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gagneja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →